Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3661 studies found for:    (heart disease OR heart attack) AND (stroke OR clot)
Show Display Options
RSS Create an RSS feed from your search for:
(heart disease OR heart attack) AND (stroke OR clot)
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed The Effectiveness of Personalized Stroke Risk Communication
Conditions: Cardiovascular Disease;   Stroke
Interventions: Other: Personalized Heart Attack and Stroke Risk;   Other: Standard Education
2 Recruiting Heart and Ischemic STrOke Relationship studY
Conditions: Brain Ischemia;   Acute Stroke;   Heart Diseases
Intervention:
3 Completed Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Conditions: Contraception;   Female Contraception
Interventions: Drug: Monophasic or triphasic Oral contraceptive tablet;   Drug: Ortho Evra transdermal patch containing 6 mg NGMN/0.75 mg EE
4 Completed Door-to-door Survey of Cardiovascular Health, Stroke and Ischemic Heart Disease in Atahualpa
Conditions: Stroke;   Ischemic Heart Disease
Intervention:
5 Completed A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Conditions: Contraception;   Female Contraception
Interventions: Drug: Transdermal Contraceptive System;   Drug: Norgestimate-containing oral contraceptives with EE
6 Completed
Has Results
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
Conditions: Myocardial Infarction;   Cardiovascular Death;   Atherothrombosis;   Stroke
Interventions: Drug: Ticagrelor 90 mg;   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor Placebo
7 Unknown  A CALIBER Study: Risk Factors for Stroke, Heart Failure, and Myocardial Infarction in Atrial Fibrillation
Conditions: Atrial Fibrillation;   Heart Failure;   Stroke;   Myocardial Infarction
Intervention:
8 Recruiting A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure
Conditions: Heart Failure;   Coronary Artery Disease
Interventions: Drug: Rivaroxaban;   Drug: Placebo;   Other: Standard of care for heart failure and coronary artery disease
9 Completed Warfarin After Anterior ST-Elevation Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: aspirin + clopidogrel;   Drug: aspirin + clopidogrel + warfarin
10 Completed
Has Results
Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke;   Myocardial Infarction;   Diabetes
Interventions: Drug: pioglitazone;   Drug: placebo
11 Completed Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization
Conditions: Heart Disease;   Myocardial Infarction;   Acute Myocardial Infarction
Interventions: Drug: Retavase 10 U IV Bolus;   Procedure: Angioplasty/Heart Catheterization;   Device: Drug eluting stent placed in heart attack related artery
12 Completed Subclinical Thyroid Dysfunction and Risk of Myocardial Infarction and Stroke
Conditions: Cardiovascular Diseases;   Heart Diseases;   Hypothyroidism;   Myocardial Infarction;   Cerebrovascular Accident
Intervention:
13 Completed
Has Results
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
Conditions: Atherosclerosis;   Ischemia;   Myocardial Infarction;   Cerebrovascular Accident;   Peripheral Arterial Disease
Interventions: Drug: Vorapaxar;   Drug: Placebo
14 Completed Relative Risks for Non-fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-containing Oral Contraceptives.
Conditions: Contraception;   Female Contraception;   Fertility Control
Intervention:
15 Unknown  Aerobic Exercise Training & the Autonomic System In Patients After Myocardial Infarction or Stroke
Condition: HR Vaiability, Aerobic Physical Fitness,Blood Pressure, Blood Sugar Level, Blood HDL, LDL
Intervention: Procedure: Aerobic exercise training
16 Terminated
Has Results
Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
Conditions: Atherosclerosis;   Myocardial Ischemia;   Myocardial Infarction
Interventions: Drug: Vorapaxar;   Drug: Placebo
17 Recruiting The "Know Your Numbers" Program in Atahualpa
Conditions: Cardiovascular Risk Factors;   Stroke;   Ischemic Heart Disease
Intervention: Other: Lifestyle counseling
18 Suspended Veliflapon (DG-031)to Prevent Heart Attacks or Stroke in Patients With a History of Heart Attack or Unstable Angina
Condition: Acute Coronary Syndrome
Intervention: Drug: veliflapon (DG-031)
19 Unknown  Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
Condition: Coronary Artery Disease
Intervention: Drug: Bivalirudin with and without eptifibatide
20 Recruiting Psychosocial Risk Factors in Stroke and Myocardial Infarction
Conditions: Myocardial Infarction;   Stroke
Interventions: Biological: blood sample;   Behavioral: questionnaires for psychosocial factors

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.